PureHoney Technologies Relocates to a New Headquarters and Research Facility.

Custom-designed 20,000 SF maximizes efficiency and enables future growth.

Billerica, MA (October 22, 2021). PureHoney Technologies (PHT) has moved to a new 20,000 SF headquarters and research facility located at 3 Federal St., Suite 300, Billerica, MA 01821. The facility has been custom-designed to maximize the efficiency of existing operations while providing for future growth. The instrumentation labs include the necessary infrastructure to operate up to 40 mass spectrometers in addition to dedicated sample preparation and BL2 labs.

Together with conventional U/HPLC-MS and ICP-MS services PureHoney Tech also offers high-throughput functional/biochemical assay development and screening using RapidFire-MS and a non-covalent binding assay using affinity-selection mass spectrometry (ASMS). Most recently the company launched a covalent protein binding assay service that enables the high-throughput screening of electrophilic libraries to identify and characterize irreversible binders of protein targets.

“Our new facility enables for streamlined operations and has been designed to match our workflows from the receipt and logging of client samples through sample prep, mass spectrometric data acquisition, and the creation of final data reports,” said Wendy Picariello, Vice President of Operations. “The facility also incorporates redundant gas generation systems, backup power generators, and automated on-site and off-site data backup and storage to minimize the effects of possible disruptions."

For further information or to schedule a tour of the new facility please log onto

PureHoney Technologies CRO Expands Capacity with Move to New Research Facility.

Execs cite growing demand for fast analysis of functional and biochemical assays using RapidFire platform.

BILLERICA, MA, (December 12, 2016).  PureHoney Technologies has moved to a larger research facility, expanding its analytical capacity using Agilent RapidFire and conventional HPLC-mass spectrometry platforms. PureHoney Technologies, a drug discovery contract research organization founded by the original developers of the RapidFire Mass Spectrometry system, uses the instrumentation to screen functional and biochemical assays with very short turnaround times. The new lab is located at 44 Manning Drive, Suite 101, Billerica, MA.

“Scientists and researchers are reaching out to us more and more to deliver fast turnaround on screening projects involving a wide range of in vitro biochemical screening assays together with cell or tissue-based functional assays,” said Can Özbal, PureHoney Technologies President and CEO, “With our larger facility and additional instrumentation we are prepared to meet the growth of applications for the ultra-fast RapidFire platform.”

Dr. Özbal noted that there are more than 50 peer reviewed research publications involving the application of RapidFire MS. Recently, Agilent Technologies announced that it is tapping PureHoney to co-develop new applications using RapidFire. Earlier this year, PureHoney announced a strategic partnership with WuXi Apptech.  For information call (978) 461-4670, log onto

Agilent Technologies and PureHoney Technologies to Develop New Applications for RapidFire/MS System

SANTA CLARA, Calif., and ACTON, Mass., Nov. 1, 2016

Agilent and PureHoney will work together to develop new applications for the Agilent RapidFire/MS System, and will independently create new workflows for pharma and biopharma research, as well as forensic toxicology and metabolomics analysis.

“Our partnership with PureHoney Technologies will enable both companies to synergistically enhance application offerings, providing scientists with a greater range of capabilities to enhance the depth and speed of pharmaceutical research,” said Monty Benefiel, Agilent vice president and general manager of the company’s Mass Spectrometry Division.

“Originally developed as a tool for label-free high-throughput screening over a decade ago, RapidFire/MS is now routinely used in applications ranging from ADME-Tox, proteomics, metabolomics, clinical research to in vivo functional assays,” said Can Özbal, PureHoney Technologies president and CEO. “We are thrilled to be partnering with Agilent to develop the next generation of applications on this versatile platform.”

The Agilent RapidFire/MS system includes drug-screening technology that provides results 10 to 100 times faster than conventional screening methods. With more than 50 peer-reviewed journal articles, RapidFire/MS is widely accepted as the benchmark platform in high-throughput mass spectrometry. This ultra-high-throughput analysis dramatically increases productivity, providing faster results.

About PureHoney Technologies

PureHoney Technologies helps pharmaceutical and biotech discovery teams accelerate drug discovery research. PureHoney offers a wide range of mass spectrometry-based analytical services specializing in functional and biochemical assays and high-throughput screening on RapidFire and conventional LC-MS platforms. Services include analytical mass spectrometry, enzymology and target characterization, custom assay development, hit identification, fragment-based screening, hit validation, structure-activity relationship screening, in vitro ADME sample screening and analytical biochemistry assays.

About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.04 billion in fiscal 2015 and employs about 12,000 people worldwide. Information about Agilent is available at